{ "id": "R44516", "type": "CRS Report", "typeId": "REPORTS", "number": "R44516", "active": true, "source": "EveryCRSReport.com", "versions": [ { "source": "EveryCRSReport.com", "id": 586699, "date": "2017-06-06", "retrieved": "2020-01-02T14:27:27.588978", "title": "Federal Research and Development Funding: FY2017", "summary": "President Obama\u2019s budget request for FY2017 included $152.333 billion for research and development (R&D), an increase of $6.195 billion (4.2%) over the estimated FY2016 enacted R&D funding level of $146.138 billion. \nFunding for R&D is concentrated in a few departments and agencies. Under President Obama\u2019s FY2017 budget request, seven federal agencies would have received 95.6% of total federal R&D funding, with the Department of Defense (47.8%) and the Department of Health and Human Services (21.5%) accounting for nearly 70% of all federal R&D funding. \nIn dollars, the largest increases in agency R&D funding in President Obama\u2019s request would have gone to the Department of Energy (up $2.755 billion, 19.1%), the Department of Defense (up $1.953 billion, 2.8%), and the Department of Health and Human Services (up $772 million, 2.4%).\nPresident Obama\u2019s FY2017 request sought to continue support for a number of multiagency R&D initiatives: the National Nanotechnology Initiative, Networking and Information Technology Research and Development program, U.S. Global Change Research Program, Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative, Precision Medicine Initiative, Cancer Moonshot, Materials Genome Initiative, National Robotics Initiative, and National Network for Manufacturing Innovation. \nAs of September 28, 2016, Congress had not completed action on any of the 12 regular appropriations bills for FY2017. The House Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the House had passed three of them. The Senate Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the Senate had passed three of them.\nOn September 29, 2016, President Obama signed into law the Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). This act, among other things, provided full-year funding for military construction and the Department of Veteran\u2019s Affairs, as well as continuing appropriations for most federal agencies through December 9, 2016, at about 99.5% of FY2016 funding. On December 10, President Obama signed into law the Further Continuing and Security Assistance Appropriations Act, 2017 (P.L. 114-254). Division A, Further Continuing Appropriations Act, 2017, generally provides continuing appropriations for most federal agencies at 99.8% of FY2016 funding through April 28, 2017, subject to other provisions in the act, pending final action on the remaining 11 regular appropriations acts for FY2017. Division B, Security Assistance Appropriations Act, 2017, included additional funding for DOD RDT&E, designated by Congress as Overseas Contingency Operations/Global War on Terrorism funding. \nIn May 2017, Congress enacted the Consolidated Appropriations Act, 2017 (P.L. 115-31). The act provides FY2017 funding for most federal agencies, except those already provided for in P.L. 114-223. Where possible, R&D funding provided under this act is identified in the following sections of this report. For some agencies, however, funding for R&D is included in appropriations line items that also include non-R&D activities; therefore, it is not possible to identify precisely how much of the funding provided in appropriations laws is allocated to R&D specifically. No further updates of this report are anticipated.\nCompletion of the annual appropriations process after the start of the fiscal year and the use of continuing resolutions can affect agencies\u2019 execution of their R&D budgets, including the delay or cancellation of planned R&D activities and acquisition of R&D-related equipment.", "type": "CRS Report", "typeId": "REPORTS", "active": true, "formats": [ { "format": "HTML", "encoding": "utf-8", "url": "https://www.crs.gov/Reports/R44516", "sha1": "4bc403ba1a863fd78ccf6946999d945cd9e57761", "filename": "files/20170606_R44516_4bc403ba1a863fd78ccf6946999d945cd9e57761.html", "images": {} }, { "format": "PDF", "encoding": null, "url": "https://www.crs.gov/Reports/pdf/R44516", "sha1": "b5b1c811122b21f7b3c7a70aa991190628316624", "filename": "files/20170606_R44516_b5b1c811122b21f7b3c7a70aa991190628316624.pdf", "images": {} } ], "topics": [ { "source": "IBCList", "id": 4852, "name": "Science & Technology R&D" } ] }, { "source": "EveryCRSReport.com", "id": 459127, "date": "2017-02-02", "retrieved": "2017-03-01T17:40:50.283307", "title": "Federal Research and Development Funding: FY2017", "summary": "President Obama\u2019s budget request for FY2017 includes $152.333 billion for research and development (R&D), an increase of $6.195 billion (4.2%) over the estimated FY2016 enacted R&D funding level of $146.138 billion. The request represents the President\u2019s R&D priorities; Congress may opt to agree with part or all of the request, or it may express different priorities through the appropriations process. In particular, Congress will play a central role in determining the growth rate and allocation of the federal R&D investment in a period of intense pressure on discretionary spending. Budget caps may limit overall R&D funding and may require movement of resources across disciplines, programs, or agencies to address priorities.\nFunding for R&D is concentrated in a few departments and agencies. Under President Obama\u2019s FY2017 budget request, seven federal agencies would receive 95.6% of total federal R&D funding, with the Department of Defense (47.8%) and the Department of Health and Human Services (21.5%) accounting for nearly 70% of all federal R&D funding. \nIn dollars, the largest increases in agency R&D funding in the President\u2019s request would go to the Department of Energy (up $2.755 billion, 19.1%), the Department of Defense (up $1.953 billion, 2.8%), and the Department of Health and Human Services (up $772 million, 2.4%).\nThe President\u2019s FY2017 request continues support for a number of multiagency R&D initiatives: the National Nanotechnology Initiative, Networking and Information Technology Research and Development program, U.S. Global Change Research Program, Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative, Precision Medicine Initiative, Cancer Moonshot, Materials Genome Initiative, National Robotics Initiative, and National Network for Manufacturing Innovation. \nAs of September 28, 2016, Congress had not completed action on any of the 12 regular appropriations bills for FY2017. The House Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the House had passed three of them. The Senate Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the Senate had passed three of them.\nOn December 10, President Obama signed into law the Further Continuing and Security Assistance Appropriations Act, 2017 (P.L. 114-254). Division A, Further Continuing Appropriations Act, 2017, generally provides continuing appropriations for most federal agencies at 99.8% of FY2016 funding through April 28, 2017, subject to other provisions in the act, pending final action on the remaining 11 regular appropriations acts for FY2017. Division B, Security Assistance Appropriations Act, 2017, includes additional funding for DOD RDT&E, designated by Congress as Overseas Contingency Operations/Global War on Terrorism funding. On September 29, 2016, President Obama signed into law the Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). This act, among other things, had provided continuing appropriations for most federal agencies through December 9, 2016, at about 99.5% of FY2016 funding.\nCompletion of the annual appropriations process after the start of the fiscal year and the use of continuing resolutions can affect agencies\u2019 execution of their R&D budgets, including the delay or cancellation of planned R&D activities and acquisition of R&D-related equipment.", "type": "CRS Report", "typeId": "REPORTS", "active": true, "formats": [ { "format": "HTML", "encoding": "utf-8", "url": "http://www.crs.gov/Reports/R44516", "sha1": "a5ca813994414398cc9d47aa8c6fd4868d157130", "filename": "files/20170202_R44516_a5ca813994414398cc9d47aa8c6fd4868d157130.html", "images": null }, { "format": "PDF", "encoding": null, "url": "http://www.crs.gov/Reports/pdf/R44516", "sha1": "3493d1211daff285b565918996132e1576c2c28a", "filename": "files/20170202_R44516_3493d1211daff285b565918996132e1576c2c28a.pdf", "images": null } ], "topics": [ { "source": "IBCList", "id": 4852, "name": "Science & Technology R&D" } ] }, { "source": "EveryCRSReport.com", "id": 458669, "date": "2017-01-27", "retrieved": "2017-02-03T19:10:24.208686", "title": "Federal Research and Development Funding: FY2017", "summary": "President Obama\u2019s budget request for FY2017 includes $152.333 billion for research and development (R&D), an increase of $6.195 billion (4.2%) over the estimated FY2016 enacted R&D funding level of $146.138 billion. The request represents the President\u2019s R&D priorities; Congress may opt to agree with part or all of the request, or it may express different priorities through the appropriations process. In particular, Congress will play a central role in determining the growth rate and allocation of the federal R&D investment in a period of intense pressure on discretionary spending. Budget caps may limit overall R&D funding and may require movement of resources across disciplines, programs, or agencies to address priorities.\nFunding for R&D is concentrated in a few departments and agencies. Under President Obama\u2019s FY2017 budget request, seven federal agencies would receive 95.6% of total federal R&D funding, with the Department of Defense (47.8%) and the Department of Health and Human Services (21.5%) accounting for nearly 70% of all federal R&D funding. \nIn dollars, the largest increases in agency R&D funding in the President\u2019s request would go to the Department of Energy (up $2.755 billion, 19.1%), the Department of Defense (up $1.953 billion, 2.8%), and the Department of Health and Human Services (up $772 million, 2.4%).\nThe President\u2019s FY2017 request continues support for a number of multiagency R&D initiatives: the National Nanotechnology Initiative, Networking and Information Technology Research and Development program, U.S. Global Change Research Program, Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative, Precision Medicine Initiative, Cancer Moonshot, Materials Genome Initiative, National Robotics Initiative, and National Network for Manufacturing Innovation. \nAs of September 28, 2016, Congress had not completed action on any of the 12 regular appropriations bills for FY2015. The House Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the House had passed three of them. The Senate Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the Senate had passed three of them.\nOn December 10, President Obama signed into law the Further Continuing and Security Assistance Appropriations Act, 2017 (P.L. 114-254). Division A, Further Continuing Appropriations Act, 2017, generally provides continuing appropriations for most federal agencies at 99.8% of FY2016 funding through April 28, 2017, subject to other provisions in the act, pending final action on the remaining 11 regular appropriations acts for FY2017. Division B, Security Assistance Appropriations Act, 2017, includes additional funding for DOD RDT&E, designated by Congress as Overseas Contingency Operations/Global War on Terrorism funding. On September 29, 2016, President Obama signed into law the Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). This act, among other things, had provided continuing appropriations for most federal agencies through December 9, 2016, at about 99.5% of FY2016 funding.\nCompletion of the annual appropriations process after the start of the fiscal year and the use of continuing resolutions can affect agencies\u2019 execution of their R&D budgets, including the delay or cancellation of planned R&D activities and acquisition of R&D-related equipment.", "type": "CRS Report", "typeId": "REPORTS", "active": true, "formats": [ { "format": "HTML", "encoding": "utf-8", "url": "http://www.crs.gov/Reports/R44516", "sha1": "e9d4d419adbd8d2612bbd6dc290dc11fabcd43ff", "filename": "files/20170127_R44516_e9d4d419adbd8d2612bbd6dc290dc11fabcd43ff.html", "images": null }, { "format": "PDF", "encoding": null, "url": "http://www.crs.gov/Reports/pdf/R44516", "sha1": "92dcbf130bbcf6a73819302b872b1635adaef3ec", "filename": "files/20170127_R44516_92dcbf130bbcf6a73819302b872b1635adaef3ec.pdf", "images": null } ], "topics": [ { "source": "IBCList", "id": 4852, "name": "Science & Technology R&D" } ] }, { "source": "EveryCRSReport.com", "id": 457776, "date": "2016-12-15", "retrieved": "2016-12-22T16:30:50.409523", "title": "Federal Research and Development Funding: FY2017", "summary": "President Obama\u2019s budget request for FY2017 includes $152.333 billion for research and development (R&D), an increase of $6.195 billion (4.2%) over the estimated FY2016 enacted R&D funding level of $146.138 billion. The request represents the President\u2019s R&D priorities; Congress may opt to agree with part or all of the request, or it may express different priorities through the appropriations process. In particular, Congress will play a central role in determining the growth rate and allocation of the federal R&D investment in a period of intense pressure on discretionary spending. Budget caps may limit overall R&D funding and may require movement of resources across disciplines, programs, or agencies to address priorities.\nFunding for R&D is concentrated in a few departments and agencies. Under President Obama\u2019s FY2017 budget request, seven federal agencies would receive 95.6% of total federal R&D funding, with the Department of Defense (47.8%) and the Department of Health and Human Services (21.5%) accounting for nearly 70% of all federal R&D funding. \nIn dollars, the largest increases in agency R&D funding in the President\u2019s request would go to the Department of Energy (up $2.755 billion, 19.1%), the Department of Defense (up $1.953 billion, 2.8%), and the Department of Health and Human Services (up $772 million, 2.4%).\nThe President\u2019s FY2017 request continues support for a number of multiagency R&D initiatives: the National Nanotechnology Initiative, Networking and Information Technology Research and Development program, U.S. Global Change Research Program, Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative, Precision Medicine Initiative, Cancer Moonshot, Materials Genome Initiative, National Robotics Initiative, and National Network for Manufacturing Innovation. \nAs of September 28, 2016, Congress had not completed action on any of the 12 regular appropriations bills for FY2015. The House Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the House had passed three of them. The Senate Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the Senate had passed three of them.\nOn December 10, President Obama signed into law the Further Continuing and Security Assistance Appropriations Act, 2017 (P.L. 114-254). Division A, Further Continuing Appropriations Act, 2017, generally provides continuing appropriations for most federal agencies at 99.8% of FY2016 funding through April 28, 2017, subject to other provisions in the act, pending final action on the remaining 11 regular appropriations acts for FY2017. Division B, Security Assistance Appropriations Act, 2017, includes additional funding for DOD RDT&E, designated by Congress as Overseas Contingency Operations/Global War on Terrorism funding. On September 29, 2016, President Obama signed into law the Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). This act, among other things, had provided continuing appropriations for most federal agencies through December 9, 2016, at about 99.5% of FY2016 funding.\nCompletion of the annual appropriations process after the start of the fiscal year and the use of continuing resolutions can affect agencies\u2019 execution of their R&D budgets, including the delay or cancellation of planned R&D activities and acquisition of R&D-related equipment.", "type": "CRS Report", "typeId": "REPORTS", "active": true, "formats": [ { "format": "HTML", "encoding": "utf-8", "url": "http://www.crs.gov/Reports/R44516", "sha1": "341b4bf18a8334e444bd8d292619487f3964b163", "filename": "files/20161215_R44516_341b4bf18a8334e444bd8d292619487f3964b163.html", "images": null }, { "format": "PDF", "encoding": null, "url": "http://www.crs.gov/Reports/pdf/R44516", "sha1": "ef93816a1362be1f3eb03f650cd70a2bdbc4cc70", "filename": "files/20161215_R44516_ef93816a1362be1f3eb03f650cd70a2bdbc4cc70.pdf", "images": null } ], "topics": [ { "source": "IBCList", "id": 4852, "name": "Science & Technology R&D" } ] }, { "source": "EveryCRSReport.com", "id": 457200, "date": "2016-11-21", "retrieved": "2016-11-28T21:04:33.559492", "title": "Federal Research and Development Funding: FY2017", "summary": "President Obama\u2019s budget request for FY2017 includes $152.333 billion for research and development (R&D), an increase of $6.195 billion (4.2%) over the estimated FY2016 enacted R&D funding level of $146.138 billion. The request represents the President\u2019s R&D priorities; Congress may opt to agree with part or all of the request, or it may express different priorities through the appropriations process. In particular, Congress will play a central role in determining the growth rate and allocation of the federal R&D investment in a period of intense pressure on discretionary spending. Budget caps may limit overall R&D funding and may require movement of resources across disciplines, programs, or agencies to address priorities.\nFunding for R&D is concentrated in a few departments and agencies. Under President Obama\u2019s FY2017 budget request, seven federal agencies would receive 95.6% of total federal R&D funding, with the Department of Defense (47.8%) and the Department of Health and Human Services (21.5%) accounting for nearly 70% of all federal R&D funding. \nIn dollars, the largest increases in agency R&D funding in the President\u2019s request would go to the Department of Energy (up $2.755 billion, 19.1%), the Department of Defense (up $1.953 billion, 2.8%), and the Department of Health and Human Services (up $772 million, 2.4%).\nThe President\u2019s FY2017 request continues support for a number of multiagency R&D initiatives: the National Nanotechnology Initiative, Networking and Information Technology Research and Development program, U.S. Global Change Research Program, Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative, Precision Medicine Initiative, Cancer Moonshot, Materials Genome Initiative, National Robotics Initiative, and National Network for Manufacturing Innovation. \nAs of September 28, 2016, Congress had not completed action on any of the 12 regular appropriations bills for FY2015. The House Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the House had passed three of them. The Senate Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the Senate had passed three of them.\nOn September 29, 2016, President Obama signed into law the Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). This act includes four divisions: Division A, the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017; Division B, provisions for Zika Response and Preparedness; Division C, Continuing Appropriations Act, 2017, a continuing resolution (CR); and Division D, which includes provisions for rescission of funds of unobligated balances from selected departments and agencies. \nThe CR provides funding for the agencies covered under the remaining 11 appropriations bills through December 9, 2016, until the enactment into law of an appropriation for any project or activity provided for in this act, or until the enactment into law of the applicable appropriations act for FY2017 without any provision for such project or activity, whichever occurs first. The CR generally provides FY2017 budget authority for FY2016 projects and activities at the rate they were funded during that fiscal year, less an across-the-board decrease of 0.496%.\nCompletion of the annual appropriations process after the start of the fiscal year and the use of continuing resolutions can affect agencies\u2019 execution of their R&D budgets, including the delay or cancellation of planned R&D activities and acquisition of R&D-related equipment.", "type": "CRS Report", "typeId": "REPORTS", "active": true, "formats": [ { "format": "HTML", "encoding": "utf-8", "url": "http://www.crs.gov/Reports/R44516", "sha1": "59c89d82af2dbf50853bd1eef7c62e3d1659a0b0", "filename": "files/20161121_R44516_59c89d82af2dbf50853bd1eef7c62e3d1659a0b0.html", "images": null }, { "format": "PDF", "encoding": null, "url": "http://www.crs.gov/Reports/pdf/R44516", "sha1": "66b1ac8b9f4e5826221ec8c02e4938a523ab54e3", "filename": "files/20161121_R44516_66b1ac8b9f4e5826221ec8c02e4938a523ab54e3.pdf", "images": null } ], "topics": [ { "source": "IBCList", "id": 4852, "name": "Science & Technology R&D" } ] }, { "source": "EveryCRSReport.com", "id": 456305, "date": "2016-10-04", "retrieved": "2016-10-17T19:20:39.961586", "title": "Federal Research and Development Funding: FY2017", "summary": "President Obama\u2019s budget request for FY2017 includes $152.333 billion for research and development (R&D), an increase of $6.195 billion (4.2%) over the estimated FY2016 enacted R&D funding level of $146.138 billion. The request represents the President\u2019s R&D priorities; Congress may opt to agree with part or all of the request, or it may express different priorities through the appropriations process. In particular, Congress will play a central role in determining the growth rate and allocation of the federal R&D investment in a period of intense pressure on discretionary spending. Budget caps may limit overall R&D funding and may require movement of resources across disciplines, programs, or agencies to address priorities.\nFunding for R&D is concentrated in a few departments and agencies. Under President Obama\u2019s FY2017 budget request, seven federal agencies would receive 95.6% of total federal R&D funding, with the Department of Defense (47.8%) and the Department of Health and Human Services (21.5%) accounting for nearly 70% of all federal R&D funding. \nIn dollars, the largest increases in agency R&D funding in the President\u2019s request would go to the Department of Energy (up $2.755 billion, 19.1%), the Department of Defense (up $1.953 billion, 2.8%), and the Department of Health and Human Services (up $772 million, 2.4%).\nThe President\u2019s FY2017 request continues support for a number of multiagency R&D initiatives: the National Nanotechnology Initiative, Networking and Information Technology Research and Development program, U.S. Global Change Research Program, Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative, Precision Medicine Initiative, Cancer Moonshot, Materials Genome Initiative, National Robotics Initiative, and National Network for Manufacturing Innovation. \nAs of September 28, 2016, Congress had not completed action on any of the 12 regular appropriations bills for FY2015. The House Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the House had passed three of them. The Senate Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the Senate had passed three of them.\nOn September 29, 2016, President Obama signed into law the Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). This act includes four divisions: Division A, the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017; Division B, provisions for Zika Response and Preparedness; Division C, Continuing Appropriations Act, 2017, a continuing resolution (CR); and Division D, which includes provisions for rescission of funds of unobligated balances from selected departments and agencies. \nThe CR provides funding for the agencies covered under the remaining 11 appropriations bills through December 9, 2016, until the enactment into law of an appropriation for any project or activity provided for in this act, or until the enactment into law of the applicable appropriations act for FY2017 without any provision for such project or activity, whichever occurs first. The CR generally provides FY2017 budget authority for FY2016 projects and activities at the rate they were funded during that fiscal year, less an across-the-board decrease of 0.496%.\nCompletion of the annual appropriations process after the start of the fiscal year and the use of continuing resolutions can affect agencies\u2019 execution of their R&D budgets, including the delay or cancellation of planned R&D activities and acquisition of R&D-related equipment.", "type": "CRS Report", "typeId": "REPORTS", "active": true, "formats": [ { "format": "HTML", "encoding": "utf-8", "url": "http://www.crs.gov/Reports/R44516", "sha1": "43cf9b4b1dd2acd7b26c34b5714a2aa6d79b092b", "filename": "files/20161004_R44516_43cf9b4b1dd2acd7b26c34b5714a2aa6d79b092b.html", "images": null }, { "format": "PDF", "encoding": null, "url": "http://www.crs.gov/Reports/pdf/R44516", "sha1": "e69b777f4f91e3430f04030e64d37ad73e5b5f9d", "filename": "files/20161004_R44516_e69b777f4f91e3430f04030e64d37ad73e5b5f9d.pdf", "images": null } ], "topics": [ { "source": "IBCList", "id": 4852, "name": "Science & Technology R&D" } ] }, { "source": "EveryCRSReport.com", "id": 453891, "date": "2016-06-24", "retrieved": "2016-09-09T19:19:08.106378", "title": "Federal Research and Development Funding: FY2017", "summary": "President Obama\u2019s budget request for FY2017 includes $152.333 billion for research and development (R&D), an increase of $6.195 billion (4.2%) over the estimated FY2016 enacted R&D funding level of $146.138 billion. The request represents the President\u2019s R&D priorities; Congress may opt to agree with part or all of the request, or it may express different priorities through the appropriations process. In particular, Congress will play a central role in determining the growth rate and allocation of the federal R&D investment in a period of intense pressure on discretionary spending. Budget caps may limit overall R&D funding and may require movement of resources across disciplines, programs, or agencies to address priorities.\nFunding for R&D is concentrated in a few departments and agencies. Under President Obama\u2019s FY2017 budget request, seven federal agencies would receive 95.6% of total federal R&D funding, with the Department of Defense (47.8%) and the Department of Health and Human Services (21.5%) accounting for nearly 70% of all federal R&D funding. \nIn dollars, the largest increases in agency R&D funding in the President\u2019s request would go to the Department of Energy (up $2.755 billion, 19.1%), the Department of Defense (up $1.953 billion, 2.8%), and the Department of Health and Human Services (up $772 million, 2.4%).\nThe President\u2019s FY2017 request continues support for a number of multiagency R&D initiatives: the National Nanotechnology Initiative, Networking and Information Technology Research and Development program, U.S. Global Change Research Program, Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative, Precision Medicine Initiative, Cancer Moonshot, Materials Genome Initiative, National Robotics Initiative, and National Network for Manufacturing Innovation. \nIn recent years, continuing resolutions and sequestration have resulted in the annual appropriations process being completed after the start of the fiscal year. This can affect agencies\u2019 execution of their R&D budgets, including the delay or cancellation of planned R&D activities and acquisition of R&D-related equipment.", "type": "CRS Report", "typeId": "REPORTS", "active": true, "formats": [ { "format": "HTML", "encoding": "utf-8", "url": "http://www.crs.gov/Reports/R44516", "sha1": "5cf0c84c091a4fae4306cf736960cd3b5aebb0a7", "filename": "files/20160624_R44516_5cf0c84c091a4fae4306cf736960cd3b5aebb0a7.html", "images": null }, { "format": "PDF", "encoding": null, "url": "http://www.crs.gov/Reports/pdf/R44516", "sha1": "3985bd5ace53036825d4a8f59cf017672c088a38", "filename": "files/20160624_R44516_3985bd5ace53036825d4a8f59cf017672c088a38.pdf", "images": null } ], "topics": [ { "source": "IBCList", "id": 2693, "name": "Science, Space, and R&D" } ] }, { "source": "EveryCRSReport.com", "id": 453085, "date": "2016-06-01", "retrieved": "2016-06-21T21:10:46.190819", "title": "Federal Research and Development Funding: FY2017", "summary": "President Obama\u2019s budget request for FY2017 includes $152.333 billion for research and development (R&D), an increase of $6.195 billion (4.2%) over the estimated FY2016 enacted R&D funding level of $146.138 billion. The request represents the President\u2019s R&D priorities; Congress may opt to agree with part or all of the request, or it may express different priorities through the appropriations process. In particular, Congress will play a central role in determining the growth rate and allocation of the federal R&D investment in a period of intense pressure on discretionary spending. Budget caps may limit overall R&D funding and may require movement of resources across disciplines, programs, or agencies to address priorities.\nFunding for R&D is concentrated in a few departments and agencies. Under President Obama\u2019s FY2017 budget request, seven federal agencies would receive 95.6% of total federal R&D funding, with the Department of Defense (47.8%) and the Department of Health and Human Services (21.5%) accounting for nearly 70% of all federal R&D funding. \nIn dollars, the largest increases in agency R&D funding in the President\u2019s request would go to the Department of Energy (up $2.755 billion, 19.1%), the Department of Defense (up $1.953 billion, 2.8%), and the Department of Health and Human Services (up $772 million, 2.4%).\nThe President\u2019s FY2017 request continues support for a number of multiagency R&D initiatives: the National Nanotechnology Initiative, Networking and Information Technology Research and Development program, U.S. Global Change Research Program, Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative, Precision Medicine Initiative, Cancer Moonshot, Materials Genome Initiative, National Robotics Initiative, and National Network for Manufacturing Innovation. \nIn recent years, continuing resolutions and sequestration have resulted in the annual appropriations process being completed after the start of the fiscal year. This can affect agencies\u2019 execution of their R&D budgets, including the delay or cancellation of planned R&D activities and acquisition of R&D-related equipment.", "type": "CRS Report", "typeId": "REPORTS", "active": true, "formats": [ { "format": "HTML", "encoding": "utf-8", "url": "http://www.crs.gov/Reports/R44516", "sha1": "6a5e13dc7a26f4d35dc44397225cad4abf0f7cf6", "filename": "files/20160601_R44516_6a5e13dc7a26f4d35dc44397225cad4abf0f7cf6.html", "images": null }, { "format": "PDF", "encoding": null, "url": "http://www.crs.gov/Reports/pdf/R44516", "sha1": "f655730473a991a4134e06f586c9b445cf94dc41", "filename": "files/20160601_R44516_f655730473a991a4134e06f586c9b445cf94dc41.pdf", "images": null } ], "topics": [ { "source": "IBCList", "id": 2693, "name": "Science, Space, and R&D" } ] } ], "topics": [ "Agricultural Policy", "Appropriations", "Domestic Social Policy", "Economic Policy", "Energy Policy", "Environmental Policy", "Intelligence and National Security", "National Defense", "Science and Technology Policy" ] }